Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
Go back to Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology| (NASDAQ: CING) | Delayed: 5.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.40 | 52 Week High | $ | |||
| Open | $5.40 | 52 Week Low | $ | |||
| Day High | $5.40 | P/E | N/A | |||
| Day Low | $5.40 | EPS | $ | |||
| Volume | 3,347 | |||||
| (NASDAQ: CINGW) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 75 | |||||
